ID: ALA2425304

Max Phase: Preclinical

Molecular Formula: C21H19N5O2S

Molecular Weight: 405.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1-n1nnc(C(=O)Nc2ncc(Cc3ccccc3)s2)c1C

Standard InChI:  InChI=1S/C21H19N5O2S/c1-14-19(24-25-26(14)17-10-6-7-11-18(17)28-2)20(27)23-21-22-13-16(29-21)12-15-8-4-3-5-9-15/h3-11,13H,12H2,1-2H3,(H,22,23,27)

Standard InChI Key:  FSABCNXEBJATRI-UHFFFAOYSA-N

Associated Targets(Human)

UO-31 46270 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

OVCAR-8 47708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

U-251 51189 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SNB-75 44215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SF-268 49410 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HOP-62 47048 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 405.48Molecular Weight (Monoisotopic): 405.1259AlogP: 3.88#Rotatable Bonds: 6
Polar Surface Area: 81.93Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.05CX Basic pKa: 0.21CX LogP: 4.77CX LogD: 4.76
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -2.18

References

1. Pokhodylo N, Shyyka O, Matiychuk V.  (2013)  Synthesis and anticancer activity evaluation of new 1,2,3-triazole-4-carboxamide derivatives,  [10.1007/s00044-013-0841-8]

Source